Cargando…
Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis
Patients with #IPF do not mount appreciable anti-spike antibody responses to two doses of #SARSCoV2 mRNA vaccine compared to the general population. National authorities should prioritise patients with IPF for booster doses. https://bit.ly/3K2KXQ0
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990384/ https://www.ncbi.nlm.nih.gov/pubmed/35509438 http://dx.doi.org/10.1183/23120541.00082-2022 |
_version_ | 1784683365308301312 |
---|---|
author | Karampitsakos, Theodoros Papaioannou, Ourania Dimeas, Ilias Tsiri, Panagiota Sotiropoulou, Vasilina Tomos, Ioannis Papanikolaou, Ilias C. Katsaras, Matthaios Kirgou, Paraskevi Daniil, Zoe Gourgoulianis, Konstantinos I. Sampsonas, Fotios Manali, Effrosyni Papiris, Spyridon Bouros, Demosthenes Tzouvelekis, Argyris |
author_facet | Karampitsakos, Theodoros Papaioannou, Ourania Dimeas, Ilias Tsiri, Panagiota Sotiropoulou, Vasilina Tomos, Ioannis Papanikolaou, Ilias C. Katsaras, Matthaios Kirgou, Paraskevi Daniil, Zoe Gourgoulianis, Konstantinos I. Sampsonas, Fotios Manali, Effrosyni Papiris, Spyridon Bouros, Demosthenes Tzouvelekis, Argyris |
author_sort | Karampitsakos, Theodoros |
collection | PubMed |
description | Patients with #IPF do not mount appreciable anti-spike antibody responses to two doses of #SARSCoV2 mRNA vaccine compared to the general population. National authorities should prioritise patients with IPF for booster doses. https://bit.ly/3K2KXQ0 |
format | Online Article Text |
id | pubmed-8990384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-89903842022-04-11 Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis Karampitsakos, Theodoros Papaioannou, Ourania Dimeas, Ilias Tsiri, Panagiota Sotiropoulou, Vasilina Tomos, Ioannis Papanikolaou, Ilias C. Katsaras, Matthaios Kirgou, Paraskevi Daniil, Zoe Gourgoulianis, Konstantinos I. Sampsonas, Fotios Manali, Effrosyni Papiris, Spyridon Bouros, Demosthenes Tzouvelekis, Argyris ERJ Open Res Research Letters Patients with #IPF do not mount appreciable anti-spike antibody responses to two doses of #SARSCoV2 mRNA vaccine compared to the general population. National authorities should prioritise patients with IPF for booster doses. https://bit.ly/3K2KXQ0 European Respiratory Society 2022-05-03 /pmc/articles/PMC8990384/ /pubmed/35509438 http://dx.doi.org/10.1183/23120541.00082-2022 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Research Letters Karampitsakos, Theodoros Papaioannou, Ourania Dimeas, Ilias Tsiri, Panagiota Sotiropoulou, Vasilina Tomos, Ioannis Papanikolaou, Ilias C. Katsaras, Matthaios Kirgou, Paraskevi Daniil, Zoe Gourgoulianis, Konstantinos I. Sampsonas, Fotios Manali, Effrosyni Papiris, Spyridon Bouros, Demosthenes Tzouvelekis, Argyris Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis |
title | Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis |
title_full | Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis |
title_fullStr | Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis |
title_full_unstemmed | Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis |
title_short | Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis |
title_sort | reduced immunogenicity of the mrna vaccine bnt162b2 in patients with idiopathic pulmonary fibrosis |
topic | Research Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990384/ https://www.ncbi.nlm.nih.gov/pubmed/35509438 http://dx.doi.org/10.1183/23120541.00082-2022 |
work_keys_str_mv | AT karampitsakostheodoros reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT papaioannouourania reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT dimeasilias reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT tsiripanagiota reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT sotiropoulouvasilina reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT tomosioannis reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT papanikolaouiliasc reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT katsarasmatthaios reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT kirgouparaskevi reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT daniilzoe reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT gourgoulianiskonstantinosi reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT sampsonasfotios reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT manalieffrosyni reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT papirisspyridon reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT bourosdemosthenes reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis AT tzouvelekisargyris reducedimmunogenicityofthemrnavaccinebnt162b2inpatientswithidiopathicpulmonaryfibrosis |